GRAIL Inc. (GRAL)
NASDAQ·Healthcare·Biotechnology
$64.08
-0.54%
Mkt Cap $2.76B
Analyst Ratings
Buy
4
Hold
3
Sell
0
Price Target (16 analysts)
$74.43
Range $56.00 – $130.00
Implied Upside
+16.2%
Consensus $74.43 vs current $64.08
NASDAQ·Healthcare·Biotechnology
$64.08
-0.54%
Mkt Cap $2.76B
Buy
4
Hold
3
Sell
0
Price Target (16 analysts)
$74.43
Range $56.00 – $130.00
+16.2%
Consensus $74.43 vs current $64.08